Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Use of ganciclovir to treat serious cytomegalovirus infections in patients with AIDS.

× No keyword cloud information.

24 in total

1. Activity of different antiviral drug combinations against human cytomegalovirus replication in vitro.

Authors: R Snoeck; G Andrei; D Schols; J Balzarini; E De Clercq
Journal: Eur J Clin Microbiol Infect Dis Date: 1992-12 Impact factor: 3.267

2. Human pharmacokinetics and tolerance of oral ganciclovir.

Authors: M A Jacobson; P de Miranda; D M Cederberg; T Burnette; E Cobb; H R Brodie; J Mills
Journal: Antimicrob Agents Chemother Date: 1987-08 Impact factor: 5.191

3. Viral colitis associated with advanced carcinoma of the prostate.

Authors: J Hughes; M W Kissin; I Muscat; T T Irvin; B J Nuttin; R Simpson
Journal: J R Soc Med Date: 1989-02 Impact factor: 5.344

4. Comparative activity of selected antiviral compounds against clinical isolates of human cytomegalovirus.

Authors: G Andrei; R Snoeck; D Schols; P Goubau; J Desmyter; E De Clercq
Journal: Eur J Clin Microbiol Infect Dis Date: 1991-12 Impact factor: 3.267

5. Patterns of resistance and sensitivity to antiviral compounds of drug-resistant strains of human cytomegalovirus selected in vitro.

Authors: R Snoeck; G Andrei; E De Clercq
Journal: Eur J Clin Microbiol Infect Dis Date: 1996-07 Impact factor: 3.267

10. Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)-cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)-guanine in the treatment of intracerebral murine cytomegalovirus infections in immunocompetent and immunodeficient mice.

Authors: J Neyts; H Sobis; R Snoeck; M Vandeputte; E De Clercq
Journal: Eur J Clin Microbiol Infect Dis Date: 1993-04 Impact factor: 3.267

Use of ganciclovir to treat serious cytomegalovirus infections in patients with AIDS.

1. Activity of different antiviral drug combinations against human cytomegalovirus replication in vitro.

2. Human pharmacokinetics and tolerance of oral ganciclovir.

3. Viral colitis associated with advanced carcinoma of the prostate.

4. Comparative activity of selected antiviral compounds against clinical isolates of human cytomegalovirus.

5. Patterns of resistance and sensitivity to antiviral compounds of drug-resistant strains of human cytomegalovirus selected in vitro.

6. Cytomegalovirus colitis in patients with acquired immunodeficiency syndrome.

7. Ocular examination and diagnosis in patients with the acquired immunodeficiency syndrome.

8. Evaluation of continuous cell lines in antiviral studies with murine cytomegalovirus.

9. Effect of 2'-nor-cyclic GMP against guinea pig cytomegalovirus infection.

10. Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)-cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)-guanine in the treatment of intracerebral murine cytomegalovirus infections in immunocompetent and immunodeficient mice.